GlassScriptPhysician profile
Kanika Agarwal
NPI 1245692433
$15,693.10
in general payments reported to CMS, 2019-2025
14 companies · $2,645 in 2025
The $2,645 reported for 2025 was more than what 91% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $308 · 2020: $148 · 2021: $2,975 · 2022: $2,137 · 2023: $1,526 · 2024: $5,955 · 2025: $2,645.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,250 · Food and Beverage: $4,875.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,250.00 |
| Food and Beverage | $4,875.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $10,028.77 | 2020-2025 | Ce-Marked Kxla System, Istent Trabecular Micro-Bypass System Model Is3, Idosetr |
| Alcon Vision LLC | $2,346.84 | 2021-2025 | Wavelight Refractive Suite, Wavelight Plus, Wavelight Ex500 Excimer Laser |
| Tarsus Pharmaceuticals, INC. | $2,186.00 | 2024-2025 | Xdemvy |
| Biotissue Holdings INC. | $338.75 | 2021-2024 | |
| Mallinckrodt Hospital Products INC. | $128.33 | 2024 | Acthar |
| Aerie Pharmaceuticals, INC. | $114.18 | 2019 | |
| Allergan, INC. | $101.22 | 2020 | |
| Harrow Eye, LLC | $100.00 | 2024 | Vevye |
| Dompe US, INC. | $89.39 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $81.87 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $81.00 | 2019 | |
| Beaver-Visitec International, INC. | $49.68 | 2021 | |
| Sight Sciences, INC. | $23.90 | 2021 | |
| Omeros Corporation | $23.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kanika Agarwal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.